Nafamostat mesylate
Tocris Bioscience, part of Bio-Techne | Catalog # 3081
Serine protease inhibitor; inhibits tryptase
Key Product Details
Description
Serine protease inhibitor; inhibits tryptase
Product Description
Nafamostat mesylate is a broad spectrum serine protease inhibitor. Displays selectivity for human tryptase when used at relatively low concentrations. Reduces eosinophil infiltration, mast cell activation and airway responsiveness in a murine model of asthma. Inhibits SARS-CoV-2 infection in vitro (EC50 = 22.50 μM).Tocris products are for biomedical research use only. They are not intended for human or veterinary use.
Product Specifications
Molecular Weight
539.59
Formula
C19H17N5O2.2CH4O3S
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate
CAS Number
82956-11-4
PubChem ID
54953
InChI Key
SRXKIZXIRHMPFW-UHFFFAOYSA-N
SMILES
CS(=O)(O)=O.NC(C1=CC=C2C(C=CC(OC(C3=CC=C(NC(N)=N)C=C3)=O)=C2)=C1)=N.CS(=O)(O)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| water | 53.96 | 100 | |
| DMSO | 53.96 | 100 |
Preparing Stock Solutions
for Nafamostat mesylate
The following data is based on the product molecular weight 539.59
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.85 mL | 9.27 mL | 18.53 mL |
| 5 mM | 0.37 mL | 1.85 mL | 3.71 mL |
| 10 mM | 0.19 mL | 0.93 mL | 1.85 mL |
| 50 mM | 0.04 mL | 0.19 mL | 0.37 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Wang Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 2020 PMID: 32020029
- Sendo A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium. Br.J.Pharmacol. 2003 PMID: 12642398
- Chen Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J.Allergy Clin.Immunol. 2006 PMID: 16815145
- Mori Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J.Pharmacol.Sci. 2003 PMID: 12939527
Product Specific Notices for Nafamostat mesylate
For research use only
Loading...
Loading...
Loading...